Co-Diagnostics, Inc.
Profit Margins
| Period | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| Jun 2017 | 87.8% | -28,424.7% | -34,671.8% |
| Sep 2017 | 100.0% | -69,478.8% | -149,865.6% |
| Mar 2018 | 100.0% | -13,174.8% | -13,513.1% |
| Jun 2018 | 100.0% | -13,958.0% | -14,152.0% |
| Sep 2018 | 100.0% | -17,159.3% | -16,926.0% |
| Dec 2018 | 13.2% | -16,846.1% | -18,000.3% |
| Mar 2019 | 86.7% | -36,896.8% | -40,246.7% |
| Jun 2019 | 37.0% | -2,218.1% | -2,183.4% |
| Sep 2019 | 50.8% | -3,982.4% | -4,218.2% |
| Dec 2019 | 51.4% | -1,495.3% | -1,598.1% |
| Mar 2020 | 68.9% | -69.9% | -68.8% |
| Jun 2020 | 75.1% | 61.2% | 62.4% |
| Sep 2020 | 73.3% | 55.2% | 72.1% |
| Dec 2020 | 84.1% | 59.0% | 47.2% |
| Mar 2021 | 83.7% | 51.6% | 39.4% |
| Jun 2021 | 90.8% | 43.1% | 35.8% |
| Sep 2021 | 89.0% | 45.3% | 38.1% |
| Dec 2021 | 87.8% | 50.5% | 36.8% |
| Mar 2022 | 85.5% | 43.3% | 51.6% |
| Jun 2022 | 81.8% | -82.6% | -53.5% |
| Sep 2022 | 84.9% | -128.3% | -26.7% |
| Dec 2022 | 63.2% | -1,863.8% | -1,563.0% |
| Mar 2023 | 16.6% | -1,653.0% | -956.1% |
| Jun 2023 | -132.1% | -6,063.7% | -4,508.9% |
| Sep 2023 | 89.6% | -363.7% | -243.5% |
| Dec 2023 | 16.5% | -332.6% | -412.8% |
| Mar 2024 | 49.9% | -2,192.9% | -1,990.4% |
| Jun 2024 | 92.0% | -289.1% | -286.0% |
| Sep 2024 | 53.6% | -1,596.4% | -1,512.4% |
| Dec 2024 | -70.8% | -7,973.9% | -7,387.4% |
| Mar 2025 | 57.1% | -17,009.7% | -14,983.5% |
| Jun 2025 | 80.3% | -4,946.1% | -4,745.0% |
| Sep 2025 | 81.9% | -4,824.5% | -4,049.3% |
| Dec 2025 | 46.0% | -10,056.7% | -9,755.1% |
| Mar 2026 | -32.8% | -6,309.1% | -6,262.3% |
| Jun 2026 | 72.7% | -3,732.5% | -3,782.4% |